Can CAR T-cell therapies achieve drug-free remission in severe refractory autoimmune diseases?
Credit available for this activity expires: 9/22/27
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/patient-journey-severe-refractory-autoimmune-rheumatic-2026a1000xbu?ecd=bdc_podcast_libsyn_mscpedu